Endovascular Aneurysm Sealing for Infrarenal Abdominal Aortic Aneurysms: 30-Day Outcomes of 105 Patients in a Single Centre  by Brownrigg, J.R.W. et al.
European Journal of Vascular and Endovascular Surgery e17aneurysms. Application of the chimney technique using the Nellix
device may offer some advantages with respect to seal between
the endograft and chimney grafts. This study aimed to investigate
the feasibility and efﬁcacy of the Nellix Endovascular Aneurysm
Sealing (EVAS) system in conjunction with chimney grafts.
A prospective evaluation of patients treated for juxtarenal and
suprarenal non-ruptured aortic aneurysms using the Nellix system
and chimney grafts was undertaken in a single Vascular Unit in the
United Kingdom.
Between February 2013 and April 2015 28 patients were
treated with EVAS in a chimney graft conﬁguration. Mean age was
74 years (8 years) and mean aneurysm size 67 mm (10 mm).
Eight patients underwent suprarenal aneurysm repair including a
chimney graft in the superior mesenteric artery. Five patients had
a double chimney conﬁguration; all the other patients were
treated with a single chimney conﬁguration. There was one 30-day
or in-hospital mortality (3.6%) due to Multi-Organ Failure (MOF)
after repair of a symptomatic aneurysm; three other patients died
within one year, due to pancreatic cancer (diagnosed after sur-
gery), pneumonia, and sepsis respectively. One patient experi-
enced a transient ischemic attack (TIA), followed by a full recovery
and two patients suffered from a minor stroke (7%). No patient
required postoperative renal replacement therapy.
The chimney technique, in combination with endovascular
aneurysm sealing, appears to offer an effective solution for jux-
tarenal and suprarenal aneurysms with adverse morphology in the
short-term.
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Three-dimensional (3D) fusion computed tomography (CT) is a
new technology that may reduce radiation in FEVAR (fenestrated
endovascular aneurysm repair). The aim of this study was to
evaluate the radiation dose effect of introducing fusion imaging to
an expert team.
Procedural details were gathered prospectively 18 consecutive
patients receiving fusion-guided (Fusion Group) FEVAR and
compared with 21 patients treated in the 12 months prior to the
implementation of routine fusion imaging (Standard Group). Pro-
cedure time (PT), radiation dose, dose-area product (DAP), ﬂuo-
roscopy time (FT), estimated blood loss (EBL) and pre- and post-
operative estimated glomerular ﬁltration rate (eGFR) were
compared between groups.
The Fusion group (n ¼ 18) received three 2 vessel-, ten 3 vessel-
, four 4 vessel-, and one single vessel-fenestrated graft(s). The
Standard group (n ¼ 21) received ﬁve 4 vessel-, eleven 3 vessel-,
four 2 vessel-, and one single-vessel graft(s). There was a signiﬁ-
cant reduction in PT for the Fusion group (median 285 mins;
interquartile range 265e323) compared with the Standard group
(420 mins; IQR 330e310 p ¼ <0.001). There were signiﬁcant re-
ductions in radiation skin dose for the Fusion group (1.65 Gy;
1.22e2.22) compared with the Standard group (4.39 Gy; 3.28e
7.05 p ¼ <0.001), and DAP; Fusion (173.64 Gy cm2; 138.33e
232.77) vs (264.93 Gy cm2; 173.37e366.85) for Standard
(p ¼ 0.001). EBL was reduced for Fusion (350 mls; 250e560)compared with Standard (1000 mls; 420e2300 p ¼ 0.01). There
was no difference in FT.
Implementation of fusion imaging signiﬁcantly reduces radia-
tion dose and other performance measures, and improves the
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Endovascular aneurysm sealing (EVAS) is a potential alternative to
endovascular aneurysm repair (EVAR) in patients with infrarenal
abdominal aortic aneurysms (AAA). The early clinical experience,
technical reﬁnements, and learning curve of EVAS in the treatment
of AAA at a single institution are presented.
105 patients were treated with EVAS between March 2013 and
November 2014. Prospective data were recorded on consecutive
patients receiving EVAS, including demographics aneurysm
morphology, and 30-day outcomes, including rates of endoleak,
limb occlusion, reintervention, and death. Postoperative imaging
consisted of duplex ultrasound and computed tomographic
angiography.
Mean age was 76  8 years and 12% were female. Adverse neck
morphology was present in 72 (69%) patients, including aneurysm
neck length <10 mm (20%), neck diameter >32 mm (18%), b-
angulation >60 (21%), and conical aneurysm neck (51%). One
death and four Type 1 endoleaks (4%) occurred within 30 days. All
four proximal endoleaks were associated with technical issues that
resulted in procedure reﬁnement, and all were in patients with
adverse proximal aortic necks. Following treatment with trans-
catheter embolization, the persistent Type 1 endoleak rate at 30
days was 0%. There were no Type 2 or Type 3 endoleaks. Angio-
plasty and adjunctive stenting were performed for postoperative
limb stenosis in three patients (3%).
EVAS is associated with reasonable 30-day outcomes, with
applicability to patients with challenging aortic morphology.
Endoleak rates should reduce with procedural experience. The
utility of EVAS will be deﬁned its durability in long-term follow-up,
although the absence of Type 2 endoleaks is encouraging.A 19-year Experience of Secondary Interventions Following EVAR
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EVAR is increasingly used as the primary mode of treatment for
aneurysmal disease. However, this technique is associated with
complications that mandate life-long follow up. We present a 19-
year single-centre experience with EVAR, speciﬁcally examining the
indications for re-intervention and the methods used.
A retrospective analysis was conducted of all EVAR cases per-
formed at the Freeman Hospital from 1995e2014.
In a 19-year period 1100 standard EVARs were performed (947
abdominal; 161 thoracic). There were a total of 303 re-in-
terventions in 212 patients (19%). Indications for re-intervention
included: Endoleak (n ¼ 180; 16%); sac expansion without endo-
leak (n ¼ 38; 14%); limb occlusion (n ¼ 40; 0.03%); disease pro-
gression (n ¼ 28; 0.03%) and rupture (n ¼ 10; 0.9%).
